AstraZeneca, P&G Dodge Prilosec OTC Antitrust Suit

Law360, New York (April 18, 2011, 3:27 PM EDT) -- A New York federal judge on Thursday tossed out American Sales Co. Inc.'s proposed class action alleging AstraZeneca AB and The Procter & Gamble Co. initiated sham patent suits in order to perpetuate an unlawful monopoly over Prilosec OTC.

U.S. District Judge P. Kevin Castel ruled the complaint did not plausibly allege a relevant product market, but left room for American Sales to amend its complaint to adequately allege all of the elements of a monopolization claim.

American Sales' allegations as to the relevant product market...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.